{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:25:44Z","timestamp":1791275144116,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00213-015-3946-6","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:36:45Z","timestamp":1430872605000},"page":"4085-4097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments"],"prefix":"10.1007","volume":"232","author":[{"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"key":"3946_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","volume":"13","author":"GE Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266\u2013271","journal-title":"Trends Neurosci"},{"key":"3946_CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainresbull.2010.04.008","volume":"83","author":"LC Amann","year":"2010","unstructured":"Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ (2010) Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull 83:147\u2013161","journal-title":"Brain Res Bull"},{"key":"3946_CR3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2174\/138161212799958576","volume":"18","author":"C Bondi","year":"2012","unstructured":"Bondi C, Matthews M, Moghaddam B (2012) Glutamatergic animal models of schizophrenia. Curr Pharm Des 18:1593\u20131604","journal-title":"Curr Pharm Des"},{"key":"3946_CR4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1301584","volume":"33","author":"V Boulougouris","year":"2008","unstructured":"Boulougouris V, Glennon JC, Robbins TW (2008) Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology 33:2007\u20132019","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/neuro.08.002.2009","volume":"3","author":"JL Brigman","year":"2009","unstructured":"Brigman JL, Ihne J, Saksida LM, Bussey TJ, Holmes A (2009) Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL\/6J mice. Front Behav Neurosci 3:2","journal-title":"Front Behav Neurosci"},{"key":"3946_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0166-4328(90)90091-R","volume":"37","author":"M Bubser","year":"1990","unstructured":"Bubser M, Schmidt WJ (1990) 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res 37:157\u201368","journal-title":"Behav Brain Res"},{"key":"3946_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson\u2019s disease. Trends Neurosci 13:272\u2013276","journal-title":"Trends Neurosci"},{"key":"3946_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-008-1205-9","volume":"200","author":"A Casta\u00f1\u00e9","year":"2008","unstructured":"Casta\u00f1\u00e9 A, Artigas F, Bortolozzi A (2008) The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology 200:281\u2013290","journal-title":"Psychopharmacology"},{"key":"3946_CR9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.npp.1300678","volume":"30","author":"EH Chartoff","year":"2005","unstructured":"Chartoff EH, Heusner CL, Palmiter RD (2005) Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 30:1324\u20131333","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1094987","volume":"304","author":"HF Clarke","year":"2004","unstructured":"Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004) Cognitive inflexibility after prefrontal serotonin depletion. Science 304:878\u2013880","journal-title":"Science"},{"key":"3946_CR11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1523\/JNEUROSCI.3690-04.2005","volume":"25","author":"HF Clarke","year":"2005","unstructured":"Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC (2005) Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 25:532\u2013538","journal-title":"J Neurosci"},{"key":"3946_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","volume":"26","author":"JT Coyle","year":"2006","unstructured":"Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365\u2013384","journal-title":"Cell Mol Neurobiol"},{"key":"3946_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","volume":"1003","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Tsai G, Goff D (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 1003:318\u2013332","journal-title":"Ann N Y Acad Sci"},{"key":"3946_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00213-010-1945-1","volume":"212","author":"S Dix","year":"2010","unstructured":"Dix S, Gilmour G, Potts S, Smith JW, Tricklebank M (2010) A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists. Psychopharmacology 212:227\u2013242","journal-title":"Psychopharmacology"},{"key":"3946_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","volume":"29","author":"M Dragunow","year":"1989","unstructured":"Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261\u2013265","journal-title":"J Neurosci Methods"},{"key":"3946_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1071-5","volume":"198","author":"A Egerton","year":"2008","unstructured":"Egerton A, Reid L, McGregor S, Cochran SM, Morris BJ, Pratt JA (2008) Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology 198:37\u201349","journal-title":"Psychopharmacology"},{"key":"3946_CR17","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","volume":"31","author":"RE Featherstone","year":"2007","unstructured":"Featherstone RE, Kapur S, Fletcher PJ (2007) The amphetamine-induced sensitized state as a model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31:1556\u20131571","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3946_CR18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.euroneuro.2014.08.012","volume":"24","author":"L Fellini","year":"2014","unstructured":"Fellini L, Kumar G, Gibbs S, Steckler T, Talpos J (2014) Re-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophrenia. Eur Neuropsychopharmacol 24:1836\u20131849","journal-title":"Eur Neuropsychopharmacol"},{"key":"3946_CR19","volume-title":"The mouse brain in stereotaxic coordinates","author":"K Franklin","year":"1997","unstructured":"Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego, California"},{"key":"3946_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","volume":"28","author":"J Frohlich","year":"2014","unstructured":"Frohlich J, Van Horn JD (2014) Reviwing the ketamine model for schizophrenia. J Psychopharmacol 28:287\u2013330","journal-title":"J Psychopharmacol"},{"key":"3946_CR21","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","volume":"23","author":"CR Gerfen","year":"2000","unstructured":"Gerfen CR (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23:S64\u2013S70","journal-title":"Trends Neurosci"},{"key":"3946_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","volume":"13","author":"AM Graybiel","year":"1990","unstructured":"Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244\u2013254","journal-title":"Trends Neurosci"},{"key":"3946_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1155\/NP.2003.107","volume":"10","author":"HJ Groenewegen","year":"2003","unstructured":"Groenewegen HJ (2003) The basal ganglia and motor control. Neural Plast 10:107\u2013120","journal-title":"Neural Plast"},{"key":"3946_CR24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","volume":"519","author":"K Hashimoto","year":"2005","unstructured":"Hashimoto K, Fujita Y, Shimizu E, Iyo M (2005) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. Eur J Pharmacol 519:114\u2013117","journal-title":"Eur J Pharmacol"},{"key":"3946_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0091-3057(96)00159-1","volume":"56","author":"M Hiramatsu","year":"1997","unstructured":"Hiramatsu M, Sasaki M, Nabeshima T, Kameyama T (1997) Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol Biochem Behav 56:73\u201379","journal-title":"Pharmacol Biochem Behav"},{"key":"3946_CR26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuropharm.2014.05.037","volume":"85","author":"T Hiyoshi","year":"2014","unstructured":"Hiyoshi T, Kambe D, Karasawa J, Chaki S (2014) Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms. Neuropharmacology 85:384\u2013396","journal-title":"Neuropharmacology"},{"key":"3946_CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00213-009-1702-5","volume":"208","author":"N Idris","year":"2010","unstructured":"Idris N, Neill J, Grayson B, Bang-Andersen B, Witten LM, Brennum LT, Arnt J (2010) Sertindole improves sub-chronic PCP induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT(2A) receptor mechanisms. Psychopharmacology 208:23\u201336","journal-title":"Psychopharmacology"},{"key":"3946_CR28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301\u20131308","journal-title":"Am J Psychiatry"},{"key":"3946_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0893-133X(00)00174-3","volume":"24","author":"JD Jentsch","year":"2001","unstructured":"Jentsch JD, Taylor JR (2001) Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 24:66\u201374","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","volume":"164","author":"CA Jones","year":"2011","unstructured":"Jones CA, Watson DJG, Fone KCF (2011) Animal models of schizophrenia. Br J Pharmacol 164:1162\u20131194","journal-title":"Br J Pharmacol"},{"key":"3946_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-458-2_1","volume":"829","author":"A Kaffman","year":"2012","unstructured":"Kaffman A, Krystal JH (2012) New frontiers in animal research of psychiatric illness. Methods Mol Biol 829:3\u201330","journal-title":"Methods Mol Biol"},{"key":"3946_CR33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","volume":"83","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Javitt DC (2010) N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83:108\u2013121","journal-title":"Brain Res Bull"},{"key":"3946_CR34","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","volume":"104","author":"L Kargieman","year":"2007","unstructured":"Kargieman L, Santana N, Mengod G, Celada P, Artigas F (2007) Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proc Natl Acad Sci U S A 104:14843\u201314848","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3946_CR35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/REVNEURO.2004.15.6.383","volume":"15","author":"AT Konkle","year":"2004","unstructured":"Konkle AT, Bielajew C (2004) Yracing the neuroanatomical profiles of reward pathways with markers of neuronal activation. Rev Neurosci 15:383\u2013414","journal-title":"Rev Neurosci"},{"key":"3946_CR36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","volume":"169","author":"JH Krystal","year":"2003","unstructured":"Krystal JH, D\u2019Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169:215\u2013233","journal-title":"Psychopharmacology"},{"key":"3946_CR37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199\u2013214","journal-title":"Arch Gen Psychiatry"},{"key":"3946_CR38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/cercor\/bhn095","volume":"19","author":"SM Landau","year":"2009","unstructured":"Landau SM, Lal R, O\u2019Neil JP, Baker S, Jagust WJ (2009) Striatal dopamine and working memory. Cereb Cortex 19:445\u2013454","journal-title":"Cereb Cortex"},{"key":"3946_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0166-4328(95)80004-2","volume":"70","author":"IP Lapin","year":"1995","unstructured":"Lapin IP, Rogawski (1995) Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behav Brain Res 70:145\u2013151","journal-title":"Behav Brain Res"},{"key":"3946_CR40","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.neuropharm.2012.01.025","volume":"62","author":"X L\u00f3pez Hill","year":"2012","unstructured":"L\u00f3pez Hill X, Scorza MC (2012) Role of the anterior thalamic nucleus in the motor hyperactivity induced by systemic MK-801 administration in rats. Neuropharmacology 62:2440\u20132446","journal-title":"Neuropharmacology"},{"key":"3946_CR41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","volume":"81","author":"ED Luby","year":"1959","unstructured":"Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug AMA. Arch Neurol Psychiatry 81:363\u2013369","journal-title":"Arch Neurol Psychiatry"},{"key":"3946_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(00)00138-8","volume":"111","author":"J Ma","year":"2000","unstructured":"Ma J, Leung LS (2000) Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav Brain Res 111:1\u201311","journal-title":"Behav Brain Res"},{"key":"3946_CR43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00213-006-0667-x","volume":"191","author":"J Ma","year":"2007","unstructured":"Ma J, Leung LS (2007) The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats. Psychopharmacology 191:961\u2013974","journal-title":"Psychopharmacology"},{"key":"3946_CR44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-009-1618-0","volume":"206","author":"SL McLean","year":"2009","unstructured":"McLean SL, Woolley ML, Thomas D, Neill JC (2009) Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology 206:403\u2013414","journal-title":"Psychopharmacology"},{"key":"3946_CR45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2010.05.043","volume":"214","author":"SL McLean","year":"2010","unstructured":"McLean SL, Neill JC, Idris NF, Marston HM, Wong EH, Shahid M (2010) Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat. Behav Brain Res 214:240\u2013247","journal-title":"Behav Brain Res"},{"key":"3946_CR46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.euroneuro.2010.06.003","volume":"21","author":"SL McLean","year":"2011","unstructured":"McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton DJ, Mackie C, Neill JC (2011) Activation of alpha 7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks inrats: implications for therapy of cognitive dysfunction in schizophrenia. Eur Neuropsychopharmacol 21:333\u2013343","journal-title":"Eur Neuropsychopharmacol"},{"key":"3946_CR47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","volume":"37","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37:4\u201315","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S146114571100085X","volume":"15","author":"A Mouri","year":"2012","unstructured":"Mouri A, Koseki T, Narusawa S, Niwa M, Mamiya T, Kano S, Sawa A, Nabeshima T (2012) Mouse strain differences in phencyclidine-induced behavioural changes. Int J Neuropsychopharmacol 15:767\u2013779","journal-title":"Int J Neuropsychopharmacol"},{"key":"3946_CR49","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.93.3.1325","volume":"93","author":"BL Murphy","year":"1996","unstructured":"Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A 93:1325\u20131329","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3946_CR50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00001756-200302100-00023","volume":"14","author":"T Nagai","year":"2003","unstructured":"Nagai T, Noda Y, Une T, Furukawa K, Furukawa H, Kan QM, Nabeshima T (2003) Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice. Neuroreport 14:269\u2013272","journal-title":"Neuroreport"},{"key":"3946_CR51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","volume":"128","author":"JC Neill","year":"2010","unstructured":"Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128:419\u2013432","journal-title":"Pharmacol Ther"},{"key":"3946_CR52","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.euroneuro.2013.09.011","volume":"24","author":"JC Neill","year":"2014","unstructured":"Neill JC, Harte MK, Haddad PM, Lydall ES, Dwyer DM (2014) Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans. Eur Neuropsychopharmacol 24:822\u2013823","journal-title":"Eur Neuropsychopharmacol"},{"key":"3946_CR53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0306-4522(96)00471-X","volume":"77","author":"G Panagis","year":"1997","unstructured":"Panagis G, Nomikos GG, Miliaressis E, Chergui K, Kastellakis A, Svensson TH, Spyraki C (1997) Ventral pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward-related brain regions. Neuroscience 77:175\u2013186","journal-title":"Neuroscience"},{"key":"3946_CR54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14:383\u2013400","journal-title":"Nat Rev Neurosci"},{"key":"3946_CR55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0306-4522(85)90002-8","volume":"16","author":"OT Phillipson","year":"1985","unstructured":"Phillipson OT, Griffiths AC (1985) The topographic order of inputs to nucleus accumbens in the rat. Neuroscience 16:275\u2013296","journal-title":"Neuroscience"},{"key":"3946_CR56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","volume":"25","author":"RC Pierce","year":"1997","unstructured":"Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192\u2013221","journal-title":"Brain Res Brain Res Rev"},{"key":"3946_CR57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/260731a0","volume":"260","author":"RM Post","year":"1976","unstructured":"Post RM, Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature 260:731\u2013732","journal-title":"Nature"},{"key":"3946_CR58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2012.03.005","volume":"231","author":"TW Robbins","year":"2012","unstructured":"Robbins TW (2012) Animal models of neuropsychiatry revisited: a personal tribute to Teitelbaum. Behav Brain Res 231:337\u2013342","journal-title":"Behav Brain Res"},{"key":"3946_CR59","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.3131879","volume":"240","author":"SM Sager","year":"1988","unstructured":"Sager SM, Sharp FR, Currant T (1988) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328\u20131331","journal-title":"Science"},{"key":"3946_CR60","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","volume":"69","author":"N Santana","year":"2011","unstructured":"Santana N, Troyano-Rodriguez E, Mengod G, Celada P, Artigas F (2011) Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biol Psychiatry 69:918\u2013927","journal-title":"Biol Psychiatry"},{"key":"3946_CR61","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbr.2009.02.007","volume":"204","author":"A Seillier","year":"2009","unstructured":"Seillier A, Giuffrida A (2009) Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of subchronic PCP and MK-801. Behav Brain Res 204:410\u2013415","journal-title":"Behav Brain Res"},{"key":"3946_CR62","first-page":"81","volume":"77","author":"H Simon","year":"1981","unstructured":"Simon H (1981) Dopaminergic A10 neurons and frontal system. J Physiol 77:81\u201395","journal-title":"J Physiol"},{"key":"3946_CR63","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.npp.1300124","volume":"28","author":"C Spielewoy","year":"2003","unstructured":"Spielewoy C, Markou A (2003) Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function. Neuropsychopharmacology 28:1106\u20131116","journal-title":"Neuropsychopharmacology"},{"key":"3946_CR64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"3946_CR65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.euroneuro.2009.07.005","volume":"19","author":"Y Tanibuchi","year":"2009","unstructured":"Tanibuchi Y, Fujita Y, Kohno M, Ishima T, Takatsu Y, Iyo M, Hashimoto K (2009) Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: a possible role of alpha1-adrenoceptors. Eur Neuropsychopharmacol 19:861\u2013867","journal-title":"Eur Neuropsychopharmacol"},{"key":"3946_CR66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00213-010-2020-7","volume":"213","author":"DM Thomson","year":"2011","unstructured":"Thomson DM, McVie A, Morris BJ, Pratt JA (2011) Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine. Psychopharmacology 213:681\u2013695","journal-title":"Psychopharmacology"},{"key":"3946_CR67","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biopsych.2014.05.019","volume":"76","author":"E Troyano-Rodr\u00edguez","year":"2014","unstructured":"Troyano-Rodr\u00edguez E, Llad\u00f3-Pelfort L, Santana N, Teruel-Mart\u00ed V, Celada P, Artigas F (2014) Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biol Psychiatry 76:937\u2013945","journal-title":"Biol Psychiatry"},{"key":"3946_CR68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10571-004-6918-7","volume":"24","author":"J V\u00e4is\u00e4nen","year":"2004","unstructured":"V\u00e4is\u00e4nen J, Ihalainen J, Tanila H, Castr\u00e9n E (2004) Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia. Cell Mol Neurobiol 24:769\u2013780","journal-title":"Cell Mol Neurobiol"},{"key":"3946_CR69","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/schbul\/sbp132","volume":"36","author":"M Buuse van den","year":"2010","unstructured":"van den Buuse M (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36:246\u2013270","journal-title":"Schizophr Bull"},{"key":"3946_CR70","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nn1846","volume":"10","author":"S Vijayraghavan","year":"2007","unstructured":"Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007) Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376\u2013384","journal-title":"Nat Neurosci"},{"key":"3946_CR71","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/376572a0","volume":"376","author":"GV Williams","year":"1995","unstructured":"Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572\u2013575","journal-title":"Nature"},{"key":"3946_CR72","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00008877-199410000-00008","volume":"5","author":"X Xu","year":"1994","unstructured":"Xu X, Domino EF (1994) Genetic differences in the locomotor response to single and daily doses of phencyclidine in inbred mouse strains. Behav Pharmacol 5:623\u2013629","journal-title":"Behav Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3946-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-015-3946-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-015-3946-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T16:32:14Z","timestamp":1566664334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-015-3946-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,7]]},"references-count":72,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3946"],"URL":"https:\/\/doi.org\/10.1007\/s00213-015-3946-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,7]]}}}